365 related articles for article (PubMed ID: 20813865)
1. SPAK-knockout mice manifest Gitelman syndrome and impaired vasoconstriction.
Yang SS; Lo YF; Wu CC; Lin SW; Yeh CJ; Chu P; Sytwu HK; Uchida S; Sasaki S; Lin SH
J Am Soc Nephrol; 2010 Nov; 21(11):1868-77. PubMed ID: 20813865
[TBL] [Abstract][Full Text] [Related]
2. Impaired phosphorylation of Na(+)-K(+)-2Cl(-) cotransporter by oxidative stress-responsive kinase-1 deficiency manifests hypotension and Bartter-like syndrome.
Lin SH; Yu IS; Jiang ST; Lin SW; Chu P; Chen A; Sytwu HK; Sohara E; Uchida S; Sasaki S; Yang SS
Proc Natl Acad Sci U S A; 2011 Oct; 108(42):17538-43. PubMed ID: 21972418
[TBL] [Abstract][Full Text] [Related]
3. Cotransporters, WNKs and hypertension: an update.
Flatman PW
Curr Opin Nephrol Hypertens; 2008 Mar; 17(2):186-92. PubMed ID: 18277153
[TBL] [Abstract][Full Text] [Related]
4. Effect of heterozygous deletion of WNK1 on the WNK-OSR1/ SPAK-NCC/NKCC1/NKCC2 signal cascade in the kidney and blood vessels.
Susa K; Kita S; Iwamoto T; Yang SS; Lin SH; Ohta A; Sohara E; Rai T; Sasaki S; Alessi DR; Uchida S
Clin Exp Nephrol; 2012 Aug; 16(4):530-8. PubMed ID: 22294159
[TBL] [Abstract][Full Text] [Related]
5. Critical role of the SPAK protein kinase CCT domain in controlling blood pressure.
Zhang J; Siew K; Macartney T; O'Shaughnessy KM; Alessi DR
Hum Mol Genet; 2015 Aug; 24(16):4545-58. PubMed ID: 25994507
[TBL] [Abstract][Full Text] [Related]
6. Discovery of Novel SPAK Inhibitors That Block WNK Kinase Signaling to Cation Chloride Transporters.
Kikuchi E; Mori T; Zeniya M; Isobe K; Ishigami-Yuasa M; Fujii S; Kagechika H; Ishihara T; Mizushima T; Sasaki S; Sohara E; Rai T; Uchida S
J Am Soc Nephrol; 2015 Jul; 26(7):1525-36. PubMed ID: 25377078
[TBL] [Abstract][Full Text] [Related]
7. SPAK isoforms and OSR1 regulate sodium-chloride co-transporters in a nephron-specific manner.
Grimm PR; Taneja TK; Liu J; Coleman R; Chen YY; Delpire E; Wade JB; Welling PA
J Biol Chem; 2012 Nov; 287(45):37673-90. PubMed ID: 22977235
[TBL] [Abstract][Full Text] [Related]
8. SPAK deficiency corrects pseudohypoaldosteronism II caused by WNK4 mutation.
Chu PY; Cheng CJ; Wu YC; Fang YW; Chau T; Uchida S; Sasaki S; Yang SS; Lin SH
PLoS One; 2013; 8(9):e72969. PubMed ID: 24039833
[TBL] [Abstract][Full Text] [Related]
9. SPAK and OSR1 play essential roles in potassium homeostasis through actions on the distal convoluted tubule.
Ferdaus MZ; Barber KW; López-Cayuqueo KI; Terker AS; Argaiz ER; Gassaway BM; Chambrey R; Gamba G; Rinehart J; McCormick JA
J Physiol; 2016 Sep; 594(17):4945-66. PubMed ID: 27068441
[TBL] [Abstract][Full Text] [Related]
10. An emerging role for SPAK in NCC, NKCC, and blood pressure regulation.
Rodan AR; Huang CL
J Am Soc Nephrol; 2010 Nov; 21(11):1812-4. PubMed ID: 20930065
[No Abstract] [Full Text] [Related]
11. Role of SPAK and OSR1 signalling in the regulation of NaCl cotransporters.
Mercier-Zuber A; O'Shaughnessy KM
Curr Opin Nephrol Hypertens; 2011 Sep; 20(5):534-40. PubMed ID: 21610494
[TBL] [Abstract][Full Text] [Related]
12. Functional interactions of the SPAK/OSR1 kinases with their upstream activator WNK1 and downstream substrate NKCC1.
Vitari AC; Thastrup J; Rafiqi FH; Deak M; Morrice NA; Karlsson HK; Alessi DR
Biochem J; 2006 Jul; 397(1):223-31. PubMed ID: 16669787
[TBL] [Abstract][Full Text] [Related]
13. WNK1 regulates vasoconstriction and blood pressure response to α 1-adrenergic stimulation in mice.
Bergaya S; Faure S; Baudrie V; Rio M; Escoubet B; Bonnin P; Henrion D; Loirand G; Achard JM; Jeunemaitre X; Hadchouel J
Hypertension; 2011 Sep; 58(3):439-45. PubMed ID: 21768522
[TBL] [Abstract][Full Text] [Related]
14. SPAK/OSR1 regulate NKCC1 and WNK activity: analysis of WNK isoform interactions and activation by T-loop trans-autophosphorylation.
Thastrup JO; Rafiqi FH; Vitari AC; Pozo-Guisado E; Deak M; Mehellou Y; Alessi DR
Biochem J; 2012 Jan; 441(1):325-37. PubMed ID: 22032326
[TBL] [Abstract][Full Text] [Related]
15. Role of the WNK-activated SPAK kinase in regulating blood pressure.
Rafiqi FH; Zuber AM; Glover M; Richardson C; Fleming S; Jovanović S; Jovanović A; O'Shaughnessy KM; Alessi DR
EMBO Mol Med; 2010 Feb; 2(2):63-75. PubMed ID: 20091762
[TBL] [Abstract][Full Text] [Related]
16. Chronic Metabolic Acidosis Activates Renal Tubular Sodium Chloride Cotransporter through Angiotension II-dependent WNK4-SPAK Phosphorylation Pathway.
Fang YW; Yang SS; Cheng CJ; Tseng MH; Hsu HM; Lin SH
Sci Rep; 2016 Jan; 6():18360. PubMed ID: 26728390
[TBL] [Abstract][Full Text] [Related]
17. SPAK differentially mediates vasopressin effects on sodium cotransporters.
Saritas T; Borschewski A; McCormick JA; Paliege A; Dathe C; Uchida S; Terker A; Himmerkus N; Bleich M; Demaretz S; Laghmani K; Delpire E; Ellison DH; Bachmann S; Mutig K
J Am Soc Nephrol; 2013 Feb; 24(3):407-18. PubMed ID: 23393317
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of NCC and NKCC2 cotransporters by kidney-specific WNK1 revealed by gene disruption and transgenic mouse models.
Liu Z; Xie J; Wu T; Truong T; Auchus RJ; Huang CL
Hum Mol Genet; 2011 Mar; 20(5):855-66. PubMed ID: 21131289
[TBL] [Abstract][Full Text] [Related]
19. Cation chloride cotransporters interact with the stress-related kinases Ste20-related proline-alanine-rich kinase (SPAK) and oxidative stress response 1 (OSR1).
Piechotta K; Lu J; Delpire E
J Biol Chem; 2002 Dec; 277(52):50812-9. PubMed ID: 12386165
[TBL] [Abstract][Full Text] [Related]
20. Dietary salt intake regulates WNK3-SPAK-NKCC1 phosphorylation cascade in mouse aorta through angiotensin II.
Zeniya M; Sohara E; Kita S; Iwamoto T; Susa K; Mori T; Oi K; Chiga M; Takahashi D; Yang SS; Lin SH; Rai T; Sasaki S; Uchida S
Hypertension; 2013 Nov; 62(5):872-8. PubMed ID: 24019400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
